The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study
Open accessAbstract
Background Comprehensive long-term data on atrial fibrillation trends in men and women are scant. We aimed to provide such data through analysis of the Framingham cohort over 50 years.Methods We investigated trends in incidence, prevalence, and risk factors for atrial fibrillation and its association with stroke and mortality after onset in 9511 participants enrolled in the Framingham Heart Study between 1958 and 2007. We analysed trends within 10 year groups (1958-67, 1968-77, 1978-87, 1988-97, and 1998-2007), stratified by sex.Findings During 50 years of observation (202,417 person-years), 1544 cases of new-onset atrial fibrillation occurred (of whom 723 [47%] were women). Between 1958-67 and 1998-2007, age-adjusted prevalence of atrial fibrillation quadrupled from 20·4 to 96·2 cases per 1000 person-years in men and from 13·7 to 49·4 cases per 1000 person-years in women; age-adjusted incidence increased from 3·7 to 13·4 new cases per 1000 person-years in men and from 2·5 to 8·6 new cases per 1000 person-years in women (ptrend<0·0001 for all comparisons). For atrial fibrillation diagnosed by electrocardiograph (ECG) during routine Framingham examinations, age-adjusted prevalence per 1000 person-years increased (12·6 in 1958-67 to 25·7 in 1998-2007 in men, ptrend=0·0007; 8·1 to 11·8 in women, ptrend=0·009). However, age-adjusted incidence of atrial fibrillation by Framingham Heart Study ECGs did not change significantly with time. Although the prevalence of most risk factors changed over time, their associated hazards for atrial fibrillation changed little. Multivariable-adjusted proportional hazards models revealed a 74% (95% CI 50-86%) decrease in stroke (hazards ratio [HR] 3·77, 95% CI 1·98-7·20 in 1958-1967 compared with 1998-2007; ptrend=0·0001) and a 25% (95% CI -3-46%) decrease in mortality (HR 1·34, 95% CI 0·97-1·86 in 1958-1967 compared with 1998-2007; ptrend=0·003) in 20 years following atrial fibrillation onset.Interpretation Trends of increased incidence and prevalence of atrial fibrillation in the community were probably partly due to enhanced surveillance. Measures are needed to enhance early detection of atrial fibrillation, through increased awareness coupled with targeted screening programmes and risk factor-specific prevention.Funding NIH, NHLBI, NINDS, Deutsche Forschungsgemeinschaft.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Similarly to incidence, age-adjusted prevalence of AF has been reported to be lower in women than in men in North America and Europe (Figure 2) (Supplementary Tables S3 and S4).”
From Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis (2016) · cites this paper as [5]
Experimental — accuracy not yet measuredIn the citing paper
“Hypertension (treated) vs. none 19 HR 1.32 (95% CI 1.08-1.60)”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [19]
In the citing paper
“Heart failure vs. none 19 HR 1.43 (95% CI 0.85-2.40)”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [19]
In the citing paper
“Older age 19 50-59 years 60-69 years 70-79 years 80-89 years HR: 1.00 (reference) 4.98 (95% CI 3.49-7.10) 7.35 (95% CI 5.28-10.2) 9.33 (95% CI 6.68-13.0)”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [19]
In the citing paper
“Obesity 19, 208 none (BMI < 25 kg/m²) overweight (BMI 25-30 kg/m²) obese (BMI ≥ 31 kg/m²) HR: 1.00 (reference) 1.13 (95% CI 0.87-1.46)1.37 (95% CI 1.05-1.78)”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [19]
In the citing paper
“Myocardial infarction vs. none 19 HR 1.46 (95% CI 1.07-1.98)”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [19]
In the citing paper
“Diabetes mellitus vs. none 19 HR 1.25 (95% CI 0.98-1.60)”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [19]
In the citing paper
“In North American and European populations, the age-adjusted incidence of AF has been estimated to be 1.5 to 2 times higher in men than in women (Supplementary Tables S1 and S2).”
From Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis (2016) · cites this paper as [5]
In the citing paper
“Elevated body mass index, hypertension, diabetes mellitus, coronary heart disease, valvular heart disease, and heart failure (HF) constitute major risk factors for AF, but the prevalence of these risk factors vary between women and men.3–5”
From Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis (2016) · cites this paper as [5]
In the citing paper
“Women with AF have higher prevalence of hypertension and valvular heart disease and lower prevalence of coronary heart disease than men with AF.5,11,34”
From Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis (2016) · cites this paper as [5]
In the citing paper
“However, in studies from North America,5 Europe,34,35 and Australia,11 women with AF are, on average, older than men.”
From Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis (2016) · cites this paper as [5]
In the citing paper
“In particular, body mass index has increased significantly (Figure 3).5”
From Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis (2016) · cites this paper as [5]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regression Analysis of Count Data
Cameron, A. C., & Trivedi, P. K. (2013) · doi:10.1017/cbo9781139013567 · Cited by 6,640
Go, A. S., Hylek, E. M., Phillips, K. A., Chang, Y., Henault, L. E., Selby, J. V., & Singer, D. E. (2001) · JAMA · doi:10.1001/jama.285.18.2370 · Cited by 6,205
Burden of valvular heart diseases: a population-based study
Nkomo, V. T., Gardin, J. M., Skelton, T. N., Gottdiener, J. S., Scott, C. G., & Enriquez-Sarano, M. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69208-8 · Cited by 4,881
Impact of Atrial Fibrillation on the Risk of Death: The Framingham Heart Study
Benjamin, E. J., Wolf, P. A., D’Agostino, R. B., Silbershatz, H., Kannel, W. B., & Levy, D. (1998) · Circulation · doi:10.1161/01.cir.98.10.946 · Cited by 4,575
Worldwide Epidemiology of Atrial Fibrillation: A Global Burden of Disease 2010 Study
Chugh, S. S., Havmoeller, R., Narayanan, K., Singh, D., Rienstra, M., Benjamin, E. J., Gillum, R. F., Kim, Y.-H., McAnulty, J. H., Zheng, Z.-J., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.005119 · Cited by 4,506
Self-citationExplaining the decrease in U.S. deaths from coronary disease, 1980–2000
Ford, E. S., Ajani, U. A., Croft, J. B., Critchley, J. A., Labarthe, D. R., Kottke, T. E., Giles, W. H., & Capewell, S. (2007) · New England Journal of Medicine · doi:10.1056/nejmsa053935 · Cited by 2,757
Benjamin, E. J. (1994) · JAMA · doi:10.1001/jama.1994.03510350050036 · Cited by 2,613
Miyasaka, Y., Barnes, M. E., Gersh, B. J., Cha, S. S., Bailey, K. R., Abhayaratna, W. P., Seward, J. B., & Tsang, T. S. M. (2006) · Circulation · doi:10.1161/circulationaha.105.595140 · Cited by 2,564
US trends in prevalence, awareness, treatment, and control of hypertension, 1988–2008
Egan, B. M. (2010) · JAMA · doi:10.1001/jama.2010.650 · Cited by 2,197
Long-term trends in the incidence of and survival with heart failure
Levy, D., Kenchaiah, S., Larson, M. G., Benjamin, E. J., Kupka, M. J., Ho, K. K. L., Murabito, J. M., & Vasan, R. S. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020265 · Cited by 2,152
Self-citation
Cited by
Sorted by citations
Items 401–500 of 1,000
He, B., Jiang, L., Hao, Z., Wang, H., & Miao, Y. (2021) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.14201 · Cited by 21
The interplay between atrial fibrillation and acute myocardial infarction
El-Shetry, M. S., Mahfouz, R. A., Frere, A.-F., & Abdeldayem, M. (2021) · British Journal of Hospital Medicine · doi:10.12968/hmed.2020.0584 · Cited by 22
Xu, W., Yang, Y., Zhu, J., Wu, S., Wang, J., Zhang, H., & Shao, X. (2022) · BMC Cardiovascular Disorders · doi:10.1186/s12872-022-02580-2 · Cited by 22
Mediterranean Diet and Atrial Fibrillation: Lessons Learned from the AFHRI Case–Control Study
Neumann, F. A., Jagemann, B., Makarova, N., Börschel, C. S., Aarabi, G., Gutmann, F., Schnabel, R. B., & Zyriax, B. (2022) · Nutrients · doi:10.3390/nu14173615 · Cited by 23
Huang, J., Tse, Y.-K., Li, H., Chen, C., Zhao, C., Liu, M.-Y., Wu, M., Ren, Q. W., Yu, S.-Y., Hung, D., et al. (2022) · Diabetes Care · doi:10.2337/dc22-1188 · Cited by 22
Xu, S., Chen, Y., Lin, R., Huáng, W., Zhou, H., Lin, Y., & Xu, M. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.997698 · Cited by 22
Yan, V. K. C., Li, H., Wei, L., Knapp, M. R. J., Wong, I. C. K., & Chan, E. W. (2023) · Drugs · doi:10.1007/s40265-023-01837-0 · Cited by 22
Chen, Q., Toorop, M. M. A., Tops, L. F., Lijfering, W. M., & Cannegieter, S. C. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.9973 · Cited by 21
Salari, S., Ejneby, M. S., Brask, J., & Elinder, F. (2017) · Acta Physiologica · doi:10.1111/apha.12895 · Cited by 22
Exercise in individuals with atrial fibrillation
Myrstad, M., Malmo, V., Ulimoen, S. R., Tveit, A., & Loennechen, J. P. (2018) · Clinical Research in Cardiology · doi:10.1007/s00392-018-1361-9 · Cited by 24
Gastrointestinal and liver diseases and atrial fibrillation: a review of the literature
Long, M. T., Ko, D., Arnold, L. M., Trinquart, L., Sherer, J. A., Keppel, S.-S., Benjamin, E. J., & Helm, R. H. (2019) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756284819832237 · Cited by 22
Knudsen, A. D., Kofoed, K. F., Gelpi, M., Sigvardsen, P. E., Mocroft, A., Kühl, J. T., Fuchs, A., Køber, L., Nordestgaard, B. G., Benfield, T., et al. (2019) · AIDS · doi:10.1097/qad.0000000000002327 · Cited by 24
Utility of risk prediction models to detect atrial fibrillation in screened participants
Poorthuis, M. H. F., Jones, N. R., Sherliker, P., Clack, R. M., de Borst, G. J., Clarke, R., Lewington, S., Halliday, A. W., & Bulbulia, R. A. (2020) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwaa082 · Cited by 22
Tanaka, N., Tanaka, K., Hirao, Y., Okada, M., Ninomiya, Y., Yoshimoto, I., Onishi, T., Koyama, Y., Okamura, A., Iwakura, K., et al. (2020) · Circulation Journal · doi:10.1253/circj.cj-20-0782 · Cited by 21
Honda, Y., Li, J., Hino, A., Tsujimoto, S., & Lee, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.680618 · Cited by 22
Contrasting trends in heart failure incidence in younger and older New Zealanders, 2006–2018
Chan, D., Kerr, A., Grey, C., Selak, V., Lee, M. A. W., Lund, M., Poppe, K., & Doughty, R. N. (2021) · Heart · doi:10.1136/heartjnl-2021-319853 · Cited by 22
Olsen, F., Uleberg, B., Jacobsen, B. K., Heuch, I., Tande, P. M., Bugge, E., & Balteskard, L. (2022) · BMC Public Health · doi:10.1186/s12889-022-12628-9 · Cited by 24
Hsu, J., Yang, Y., Chuang, S.-L., Lin, L., & Chen, T. H.-H. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01767-x · Cited by 22
Falchi, L., Baron, J. M., Orlikowski, C. A., & Ferrajoli, A. (2016) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2016.011 · Cited by 21
Gwyn, J. C., Thomas, M. R., & Kirchhof, P. F. (2017) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvx002 · Cited by 21
Mid‐life and late‐life vascular risk factor burden and neuropathology in old age
Conner, S. C., Pase, M. P., Carneiro, H. A., Raman, M. R., McKee, A. C., Alvarez, V. E., Walker, J. M., Satizábal, C. L., Himali, J. J., Stein, T. D., et al. (2019) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.50936 · Cited by 21
Rate control strategies for atrial fibrillation
Alobaida, M., & Alrumayh, A. (2021) · Annals of Medicine · doi:10.1080/07853890.2021.1930137 · Cited by 28
Wu, C., Li, X., Lv, Z., Chen, Q., Lou, Y., Mao, W., & Zhou, X. (2021) · Scientific Reports · doi:10.1038/s41598-021-96820-8 · Cited by 21
Kreimer, F., Mügge, A., & Gotzmann, M. (2022) · Clinical Research in Cardiology · doi:10.1007/s00392-022-02000-7 · Cited by 23
Thirty‐Year Trends in the Incidence of Atrial Fibrillation: The ARIC Study
Ghelani, K., Chen, L. Y., Norby, F. L., Soliman, E. Z., Koton, S., & Alonso, Á. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.121.023583 · Cited by 21
Prevalence and Incidence Rates of Atrial Fibrillation in Denmark 2004–2018
Hegelund, E. R., Kjerpeseth, L. J., Mortensen, L. H., Igland, J., Berge, T., Anjum, M., Tell, G. S., & Ariansen, I. (2022) · Clinical Epidemiology · doi:10.2147/clep.s374468 · Cited by 21
Park, C. S., Choi, E., Kyung-DoHan, Yoo, J., Ahn, H., Kwon, S., Lee, S., Oh, S., & Lip, G. Y. H. (2022) · Diabetes Care · doi:10.2337/dc22-1655 · Cited by 21
Parise, O., Parise, G., Vaidyanathan, A., Occhipinti, M., Gharaviri, A., Tetta, C., Bidar, E., Maesen, B. A. E., Maessen, J. G., Meir, M. L., et al. (2023) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd10020082 · Cited by 21
Non-coding RNA and arrhythmias: expression, function, and molecular mechanism
Zeng, Y., Wu, N., Zhang, Z., Zhong, L., Li, G., & Li, Y. (2023) · EP Europace · doi:10.1093/europace/euad047 · Cited by 21
Miyauchi, S., Tokuyama, T., Takahashi, S., Hiyama, T., Okubo, Y., Okamura, S., Miyamoto, S., Oguri, N., Takasaki, T., Katayama, K., et al. (2023) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2023.01.029 · Cited by 23
Metabolic Syndrome and Atrial Fibrillation: Different Entities or Combined Disorders
Zakynthinos, G. Ε., Tsolaki, V., Oikonomou, E. K., Vavouranakis, M., Siasos, G., & Zakynthinos, E. G. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13091323 · Cited by 23
Gut microbiome associated dysbiosis: Limited regimens and expanding horizons of phage therapy
Singha, B., Rawat, B. S., Venkataraman, R., Nair, T., Rosenn, E. H., & Soni, V. (2023) · Aspects of Molecular Medicine · doi:10.1016/j.amolm.2023.100029 · Cited by 23
Atrial Fibrillation and Risk of Dementia/Cognitive Decline.
SHAH, A. D., Merchant, F. M., & DeLurgio, D. B. (2016) · PubMed · doi:10.4022/jafib.1353 · Cited by 21
Wei, Y. Q., Xu, J., Wu, H., Zhou, G., Chen, S., Wang, C., Shen, Y., Yang, S., Wang, B., He, Z., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-24878-y · Cited by 21
A Computational Framework to Benchmark Basket Catheter Guided Ablation in Atrial Fibrillation
Alessandrini, M., Valinoti, M., Unger, L. A., Oesterlein, T. G., Dössel, O., Corsi, C., Loewe, A., & Severi, S. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01251 · Cited by 19
Pharmacotherapeutic strategies for atrial fibrillation in pregnancy
Georgiopoulos, G. A., Tsiachris, D., Kordalis, A., Kontogiannis, C., Spartalis, Μ., Pietri, P., Magkas, N., & Stefanadis, C. (2019) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2019.1621290 · Cited by 23
Wang, Z., Wang, B., Li, X., Zhang, S., Wu, S., & Xia, Y. (2020) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2020.06.026 · Cited by 20
Regueiro, A., Cruz‐González, I., Bethencourt, A., y, L. N.-F., Champagne, J., Asmarats, L., Jiménez‐Quevedo, P., Gabella, T. R., Rama-Merchán, J. C., Puri, R., et al. (2018) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-018-0356-9 · Cited by 20
Glycemic control is associated with atrial structural remodeling in patients with type 2 diabetes
Wang, Q., Wang, J., Wang, P., Wang, L., Jia, L., Ling, X., Wang, X., Min, J., Shen, H. M., Xiao, J., et al. (2019) · BMC Cardiovascular Disorders · doi:10.1186/s12872-019-1249-2 · Cited by 20
Hacke, W., Bassand, J., Virdone, S., Camm, A. J., Fitzmaurice, D. A., Fox, K. A. A., Goldhaber, S. Z., Goto, S., Haas, S. K., Kayani, G., et al. (2019) · International Journal of Stroke · doi:10.1177/1747493019891516 · Cited by 20
The cardiovascular consequences of hyperaldosteronism
Rossi, G. P., Seccia, T. M., Maiolino, G., & Cesari, M. (2020) · Annales d Endocrinologie · doi:10.1016/j.ando.2020.02.006 · Cited by 20
Lin, K., Chen, K., Li, S., Cai, M., Yuan, M., Wang, Y., Zhang, X., Wei, M., Yan, M., Ma, X., et al. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.615065 · Cited by 20
Miyauchi, S., Tokuyama, T., Shintani, T., Nishi, H., Hamamoto, Y., Ouhara, K., Furusho, H., Miyauchi, M., Komatsuzawa, H., & Nakano, Y. (2021) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.14952 · Cited by 19
Wang, F., Ahat, X., Liang, Q., Ma, Y., Sun, M., Lin, L., Li, T., Duan, J., & Sun, Z. (2021) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2021.147106 · Cited by 20
Long-term risk of adverse outcomes according to atrial fibrillation type
Blum, S., Aeschbacher, S., Coslovsky, M., Meyre, P. B., Reddiess, P., Ammann, P., Erné, P., Moschovitis, G., Valentino, M. D., Shah, D. C., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-05688-9 · Cited by 20
Zhou, L., He, L., Wang, W., Li, C., Li, S., Tang, R., Sang, C., Liu, N., Jiang, C., Yu, R., et al. (2022) · EP Europace · doi:10.1093/europace/euac169 · Cited by 20
Toprak, B., Brandt, S., Brederecke, J., Gianfagna, F., Vishram‐Nielsen, J. K. K., Ojeda, F., Costanzo, S., Börschel, C. S., Söderberg, S., Katsoularis, I., et al. (2022) · EP Europace · doi:10.1093/europace/euac260 · Cited by 20
A History of Left Atrial Appendage Occlusion
Holmes, D. R., Schwartz, R. S., Latus, G. G., & Tassel, R. A. V. (2018) · Interventional Cardiology Clinics · doi:10.1016/j.iccl.2017.12.005 · Cited by 20
Chen, H., Li, S., Chen, L., Wang, W., Wang, Y., & Yan, X.-W. (2018) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563218788386 · Cited by 20
van Laar, C., Bentala, M., Weimar, T., Doll, N., Swaans, M. J., Molhoek, S. G., Hofman, F. N., Kelder, J. C., & van Putte, B. P. (2018) · EP Europace · doi:10.1093/europace/euy323 · Cited by 20
Novel Risk Modeling Approach of Atrial Fibrillation With Restricted Mean Survival Times
Stærk, L., Preis, S. R., Lin, H., Casas, J. P., Lunetta, K. L., Weng, L.-C. C., Anderson, C. D., Ellinor, P. T., Lubitz, S. A., Benjamin, E. J., et al. (2020) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.119.005918 · Cited by 20
Ионин, В. А., Ивановна, Б. Е., Filatova, А. G., Баранова, Е. И., & Shlyakhto, E. V. (2020) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2020-26-2-192-201 · Cited by 20
Molecular imaging of atrial myopathy: Towards early AF detection and non-invasive disease management
Ezeani, M., Hagemeyer, C. E., Lal, S., & Niego, B. (2020) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2020.12.002 · Cited by 20
Verma, K. P., & Wong, M. C. G. (2019) · Australian Journal of General Practice · doi:10.31128/ajgp-12-18-4787 · Cited by 20
da Silva, D. S., Coan, A. C., & Avelar, W. M. (2019) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2019.02.027 · Cited by 20
Li, Y., Jiang, C., He, L., Li, X., Hou, X., Chang, S., Lip, G. Y. H., Du, X., Dong, J., & Ma, C. (2019) · Medical Science Monitor · doi:10.12659/msm.919366 · Cited by 19
Chua, W., Law, J. P., Cardoso, V. R., Purmah, Y., Neculau, G., Qamar, M. J. U., Russell, K., Turner, A., Tull, S. P., Neháj, F., et al. (2021) · PLoS Medicine · doi:10.1371/journal.pmed.1003405 · Cited by 19
Sensi, F. D., Penela, D., Soto‐Iglesias, D., Berruezo, A., & Limbruno, U. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10112277 · Cited by 19
An, S., Ahn, C., Moon, S., Sim, E. J., & Park, S.-K. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12030505 · Cited by 19
Kim, Y. G., Lee, H., Kim, H., Kim, M., Jeong, J. H., Choi, Y. Y., Shim, J., Choi, J., & Kim, Y. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.01.013 · Cited by 19
Bouazizi, K., Rahhal, A., Kuśmia, S., Evin, M. A., Defrance, C., Cluzel, P., Berthet, M., Atassi, F., Leprince, P. N., Lebreton, G., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0205104 · Cited by 19
Pharmacological Cardioversion With Antazoline in Atrial Fibrillation: The Results of the CANT Study
Wybraniec, M. T., Wróbel, W., Wilkosz, K., Wrona‐Kolasa, K., Bula, K., & Mizia‐Stec, K. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.010153 · Cited by 19
Atrial Fibrillation and Mitral Valve Prolapse
Borger, M. A., MANSOUR, M. C., & Levine, R. A. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.11.018 · Cited by 19
Flavonoid intake and its association with atrial fibrillation
Bondonno, N. P., Murray, K., Bondonno, C. P., Lewis, J. R., Croft, K. D., Kyrø, C., Gislason, G., Tjønneland, A. M., Scalbert, A., Cassidy, A., et al. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2020.04.025 · Cited by 19
Mitręga, K. A., Lip, G. Y. H., Średniawa, B., Sokal, A., Streb, W., Przyłudzki, K., Zdrojewski, T. R., Wierucki, Ł., Rutkowski, M., Bandosz, P., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10112321 · Cited by 19
Blum, S., & Conen, D. (2022) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2022.10.013 · Cited by 21
Czapla, M., Uchmanowicz, I., Juárez‐Vela, R., Durante, Á., Kałużna‐Oleksy, M., Łokieć, K., Baeza‐Trinidad, R., & Smereka, J. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1086715 · Cited by 19
Hsu, N., Tsao, H.-M., Chen, H., Lo, S.-S., Chen, S.-A., & Chou, P. (2015) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.238.75 · Cited by 19
Hammond‐Haley, M., Providencia, R. A., & Lambiase, P. D. (2017) · EP Europace · doi:10.1093/europace/eux178 · Cited by 22
Ikoma, T., Naruse, Y., Kaneko, Y., Sakakibara, T., Narumi, T., Sano, M., Mogi, S., Suwa, K., Ohtani, H., Saotome, M., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0266939 · Cited by 18
Sex Differences in the Association Between Hypertension and Incident Atrial Fibrillation
Kanazawa, S., Kaneko, H., Yano, Y., Suzuki, Y., Okada, A., Matsuoka, S., Fujiu, K., Michihata, N., Jo, T., Takeda, N., et al. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.122.026240 · Cited by 18
Bentea, G. P., Berdaoui, B., Morissens, M., van de Borne, P., & Rodriguez, J. C. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.124.037552 · Cited by 24
Integrated care of patients with atrial fibrillation: the 2016 ESC atrial fibrillation guidelines
Kirchhof, P. F. (2017) · Heart · doi:10.1136/heartjnl-2016-310843 · Cited by 18
Stroke Prevention in Atrial Fibrillation
Voukalis, C., Shantsila, E., & Lip, G. Y. H. (2017) · The Journal of the Royal College of Physicians of Edinburgh · doi:10.4997/jrcpe.2017.105 · Cited by 18
Plasma Phospholipid Fatty Acids and Risk of Atrial Fibrillation: A Mendelian Randomization Study
Yuan, S., & Larsson, S. C. (2019) · Nutrients · doi:10.3390/nu11071651 · Cited by 18
Simone, V. D., Mugnolo, A., Zanotto, G., & Morando, G. (2020) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000000986 · Cited by 18
Atrial remodeling and atrial fibrillation recurrence after catheter ablation
Nedios, S., Lindemann, F., Heijman, J., Crijns, H. J. G. M., Bollmann, A., & Hindricks, G. (2021) · Herz · doi:10.1007/s00059-021-05050-1 · Cited by 18
Saglietto, A., Fois, M., Ridolfi, L., Ferrari, G. M. D., Anselmino, M., & Scarsoglio, S. (2022) · Scientific Reports · doi:10.1038/s41598-022-04897-6 · Cited by 18
Gottschalk, S., Kany, S., König, H., Crijns, H. J. G. M., Vardas, P. E., Camm, A. J., Wegscheider, K., Metzner, A., Rillig, A., Kirchhof, P. F., et al. (2023) · EP Europace · doi:10.1093/europace/euad051 · Cited by 21
Sawant, A. C., Seibolt, L., Sridhara, S., Rodriguez, J., Distler, E., Murarka, S., Lazkani, M., Kumar, A., Kanwar, N., Prakash, M. P. H., et al. (2019) · Cardiovascular revascularization medicine · doi:10.1016/j.carrev.2019.08.001 · Cited by 18
LaBarbera, M. A., Atta-Fosu, T., Feeny, A. K., Firouznia, M., McHale, M. L., Cantlay, C., Roach, T., Axtell, A., Schoenhagen, P., Barnard, J., et al. (2021) · IEEE Journal of Translational Engineering in Health and Medicine · doi:10.1109/jtehm.2021.3134160 · Cited by 17
Ghajar, A., Essa, M., DeLago, A. J., Parvez, A., Aryan, Z., Shalhoub, J., Hammond‐Haley, M., Hartley, A., Sargsyan, V., Salciccioli, J. D., et al. (2022) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.14643 · Cited by 17
Aktan, A., Güzel, T., Aslan, B., Kılıç, R., Günlü, S., Özbek, M., Arslan, B., Demir, M., & Ertaş, F. (2023) · Kardiologia Polska · doi:10.33963/kp.a2022.0287 · Cited by 17
Jansson, M., Själander, S., Sjögren, V., Björck, F., Renlund, H., Norrving, B. G., & Själander, A. (2023) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-022-02763-w · Cited by 16
Zhang, B., Cheng, W., Kaisaier, W., Gu, Z., Zhu, W., & Jiang, Q. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e21740 · Cited by 17
Wu, Q., Zhao, Y. W., Liu, L., Liu, Y., & Liu, J. (2023) · BMJ Global Health · doi:10.1136/bmjgh-2023-013311 · Cited by 17
Lu, Z., Ntlapo, N., Tilly, M. J., Geurts, S., Aribas, E., Ikram, M. A., de Groot, N. M. S., & Kavousi, M. (2022) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwae045 · Cited by 22
Bhonsale, A., Zhu, J., Thoma, F. W., Koscumb, S., Kancharla, K., Voigt, A., Magnani, J. W., Estes, N. A. M., Saba, S., Marroquin, O. C., et al. (2024) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.123.012143 · Cited by 17
Du, J., Liu, J., Wang, X., Wang, X., Ma, Y., Zhang, S., Li, Z., Ma, J., & Liu, J. (2025) · Biology Direct · doi:10.1186/s13062-025-00618-x · Cited by 22
Taking the pulse of atrial fibrillation
Potter, B. J., & LeLorier, J. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61991-7 · Cited by 17
daVinci Study Group, Saji, N., Kimura, K., Tateishi, Y., Fujimoto, S., Kaneko, N., Urabe, T., Tsujino, A., & Iguchi, Y. (2016) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-016-1376-x · Cited by 17
Gregers, E., Ahlberg, G., Christensen, T., Jabbari, J., Larsen, K. O., Herfelt, C. B., Henningsen, K. M. A., Andreasen, L., Thiis, J. J., Lund, J., et al. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.05.027 · Cited by 17
Prevalence of Atrial Fibrillation in Korean Population
Lee, S., & Choi, E. (2017) · International Journal of Arrhythmia · doi:10.18501/arrhythmia.2017.030 · Cited by 17
Prognostic Significance of Echocardiographic Measures of Cardiac Remodeling
von Jeinsen, B., Short, M. I., Larson, M. G., Xanthakis, V., McManus, D. D., Benjamin, E. J., Mitchell, G. F., Aragam, J. R., Cheng, S. C., & Vasan, R. S. (2019) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2019.08.001 · Cited by 17
Goldenberg, G. R., Hamdan, A., Barsheshet, A., Neeland, I. J., Kadmon, E., Yavin, H. D., Omelchenko, A., Erez, A., Marcuschamer, I., Kornowski, R., et al. (2021) · International journal of cardiac imaging · doi:10.1007/s10554-021-02244-w · Cited by 17
Linz, B. M., Hertel, J. N., Jespersen, T., & Linz, D. (2022) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2022.04.009 · Cited by 21
Rim, T. H., Oh, J., Lee, C. S., Lee, S. C., Kang, S., & Kim, S. S. (2016) · Scientific Reports · doi:10.1038/srep34708 · Cited by 17
Talboom-Kamp, E. P. W. A., Verdijk, N. A., Kasteleyn, M. J., Harmans, L. M., Talboom, I. J. S. H., Numans, M. E., & Chavannes, N. H. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-017909 · Cited by 16
Burden of atrial fibrillation in Māori and Pacific people in New Zealand: a cohort study
Gu, Y., Doughty, R. N., Freedman, B., Kennelly, J., Warren, J., Harwood, M. L. N., Hulme, R., Paltridge, C., Teh, R., Rolleston, A. K., et al. (2017) · Internal Medicine Journal · doi:10.1111/imj.13648 · Cited by 16
Mourtzinis, G., Eryd, S. A., Rosengren, A., Bjorck, L. M., Adiels, M., Johannsson, G., & Manhem, K. (2018) · European Journal of Preventive Cardiology · doi:10.1177/2047487318759853 · Cited by 17
Metadata
- Authors
- Schnabel, R. B., Yin, X., Gona, P., Larson, M. G., Beiser, A. S., McManus, D. D., Newton-Cheh, C., Lubitz, S. A., Magnani, J. W., Ellinor, P. T., Seshadri, S., Wolf, P. A., Vasan, R. S., Benjamin, E. J., & Levy, D.
- Affiliations
- Framingham Heart Study (US)
- Boston University (US)
- University of Massachusetts Chan Medical School (US)
- Harvard University (US)
- Broad Institute (US)
- Corresponding author
- Schnabel, Renate B
- ORCID
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2015-07
- Volume
- 386
- Issue
- 9989
- Pages
- 154-162
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- PMC
- PMC4553037
- OpenAlex
- W1924098982
- Cited by
- 1,746
- References
- 32
- Citations by year
- 2026: 126 · 2025: 209 · 2024: 253 · 2023: 192 · 2022: 198 · 2021: 155 · 2020: 145 · 2019: 141 · 2018: 120 · 2017: 110 · 2016: 76 · 2015: 20
- FWCI
- 79.02
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- The Journal of the American Medical Association (JAMA) Network (American Medical Association) (submittedVersion)
- Funders
- NIH/NHLBI (contract N01-HC-25195, grant 1K23HL114724)
- NIH (grants 1RC1HL101056, HL102214, and AG028321, grant 2R01HL092577, grants 1U01HL105268-01 and KL2RR031981)
- Fondation Leducq (14CVD01) and NIH grants (1R01HL092577, 1RC1HL101056, 1R01HL102214, 1R01AG028321, R01HL104156, and 1K24HL105780)
- American Heart Association Established Investigator Award (13EIA14220013)
- Deutsche Forschungsgemeinschaft (German Research Foundation) Emmy Noether Program (SCHN 1149/3-2)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Keywords
- atrial fibrillation, prevalence trends, incidence trends, sex differences, risk factors, stroke, mortality, Framingham Heart Study, electrocardiogram screening, atrial fibrillation screening, atrial fibrillation prevention, cardiovascular disease prevention, long-term cohort follow-up
- MeSH terms
- Aged, Aged, 80 and over, Atrial Fibrillation, Electrocardiography, Female, Humans, Male, Middle Aged, Mortality, Risk Factors, United States, Cohort Studies, Incidence, Prevalence, Age Distribution, Sex Distribution, Stroke
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
